Form 10-Q, quarterly report
Latigo Biotherapeutics, Inc., 10-Q filed 2026-09-03
Published 3 Sep 2026 · retrieved 8 Sep 2026, 02:30 EDT · version 1Official source
The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.
Filing record
¶1
10-Q filed with the Securities and Exchange Commission by Latigo Biotherapeutics, Inc. (CIK 0002056611) on 2026-09-03.
¶2
Accession number 0001193125-26-381969. EDGAR reports the filing package as 11 MB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/2056611/000119312526381969/0001193125-26-381969-index.htm.